3Sz6mrn B, Nagy G, Varga T, et al. Changes in cognitive function in patients with diabetes mellitus [ J ]. Orv Hetil,2012,153 (9):323-329.
4Duff K,Humphreys Clark JD,O' Bryant SE,et al.Utility of the RBANS in detecting cognitive impairment associated with Alzbeimer's disease:sensitivity, specificity,and positive and negative predictive powers [ J ].Arch Clin Neuropsychol,2008,23 ( 5 ):603-612.
5Badenes Guia D,Casas Hernanz L,Cejudo Bolivar J C,et al.Evaluation of the capacity to drive in patients diagnosed ofmild cognitive impairment and dementia [ J ].Neurologia,2008,23 ( 9 ):575-582.
6Panee J.Monocyte Chemoattractant protein 1 (MCP-1 ) in obesity and dlabetes[ J ].Cytokirte,2012,60( 1 ): 1-12.
7Catalrn V, G6mez-Ambrosi J, Ramirez B, et al. Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass[J].Obes Surg,2007,17( 11 ):1464-1474.
8Biessels GJ, Staekenborg S, Brunner E, et al.Risk of dementia in diabetes mellitus: a systematic review [ J ]. Lancet Neurol, 2006,5 ( 1 ): 64-74.
9Okereke OI,Kang JH,Cook NR,et al. Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults[J]. Am Geriatr Soc, 2008,56(6 ):1028-1036.
10Westin K,Buchhave P,Nielsen H, et al.CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer's disease [ J ].PLoS One, 2012,7( 1 ):e30525.
